Posted on 13 January 2013.
UPDATE 2-Drugs group Lundbeck's shares hit by profit warning
Lundbeck is working to find new drugs to replace lost revenue from products coming off patent protection such as its antidepressant Cipralex, which is sold as Lexapro in the United States and Japan, and Alzheimer's drug Ebixa. Wiinberg said 2014 would …
Full News here – Read more on Reuters